Exchange: NASDAQ·Updated 04:10 PM EST

About QNRX

About

Quoin Pharmaceuticals Ltd. engages in the development of therapeutic products for the treatment of rare and orphan diseases. Its product pipeline includes QRX003, QRX004, QRX007, and QRX008. The company was founded by Michael Myers and Denise Carter on March 5, 2018 and is headquartered in Ashburn, VA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
4

Frequently Asked Questions

Advertisement|Remove ads.